Trial · NCT03504917
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline at Week 24 on the Vineland Adaptive Behavior Scales (Vineland-II) Two-domain Composite (2DC) Score. | Week 24 | ITT Population | Score | MEAN |
| SECONDARY | Change From Baseline at Week 12 on the Vineland-II 2DC Score | Week 12 | ITT Population | Score | MEAN |
| SECONDARY | Change From Baseline at Weeks 12 and 24 in the Pediatric Quality of Life (PedsQL) Inventory Generic Core Scales, Version 4.0, on Summary and Total Scores | Weeks 12 and 24 | ITT Population | Score | MEAN |
| SECONDARY | Change From Baseline at Weeks 12 and 24 in the Vineland-II Adaptive Behavior Composite Standard Score | Weeks 12 and 24 | ITT Population | Score | MEAN |
| SECONDARY | Change From Baseline at Week 12 and 24 on the Vineland-II Socialization Domain Standard Score | Baseline, Weeks 12 and 24 | ITT Population | Score | MEAN |
| SECONDARY | Change From Baseline at Weeks 12 and 24 on the Vineland-II Communication Domain Standard Score | Weeks 12 and 24 | ITT Population | Score | MEAN |
| SECONDARY | Change From Baseline at Weeks 12 and 24 on the Vineland-II Daily Living Skills Domain Standard Score | Weeks 12 and 24 | ITT Population | Score | MEAN |
| SECONDARY | Change From Baseline in Severity of Clinical Impressions as Measured by Clinical Global Impression-Severity (CGI-S) | Weeks 12 and 24 | ITT Population | Percentage of Participants | NUMBER |
| SECONDARY | Improvements in Clinical Impressions, as Measured by Clinical Global Impression-Improvement (CGI-I) | Weeks 12 and 24 | ITT Population | Percentage of Participants | NUMBER |
| SECONDARY | Change From Baseline at Weeks 12 and 24 in the Hamilton Anxiety Rating Scale (HAM-A) Total and Domain Scores | Weeks 12 and 24 | ITT Population | Score | MEAN |
| SECONDARY | Proportion of Subjects With a >=6-point Improvement in Vineland-II 2DC Score | Weeks 12 and 24 | ITT Population | Percentage of Participants | NUMBER |
| SECONDARY | Percentage of Participants With Adverse Events | Week 24 and Up to Approximately 2 Years | Safety Population | Percentage of Participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03504917/outcomes